Abstract
Sodium dodecyl sulphate-supported iron silicophosphate (SDS/FeSP) nanocomposite was successfully fabricated by the co-precipitation method. The SDS/FeSP nanocomposite was investigated as a drug carrier for ondansetron. The cumulative drug release of ondansetron was observed at various pH values for different time intervals, i.e., from 20 min to 48 h. A ranking of the drug release was observed at different pHs; pH 2.2 > saline (pH 5.5) > pH 7.4 > pH 9.4 > distilled water. Maximum release of encapsulated drug was found to be about 45.38% at pH 2.2. The cell viability tests of SDS/FeSP nanocomposite concluded that SDS/FeSP nanocomposite was non-cytotoxic in nature.
| Original language | English |
|---|---|
| Article number | 414 |
| Journal | International Journal of Environmental Research and Public Health |
| Volume | 15 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2018 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
- Drug delivery
- Nanocomposite
- Ondansetron
- Sodium dodecyl sulphate
ASJC Scopus subject areas
- Pollution
- Public Health, Environmental and Occupational Health
- Health, Toxicology and Mutagenesis
Fingerprint
Dive into the research topics of 'Sodium dodecyl sulphate-supported nanocomposite as drug carrier system for controlled delivery of ondansetron'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver